Clinical Trials on Disease, Viral in Germany

Total 21677 results

U.S. Army Medical Research and Development Command

Recruiting

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Viral Hemorrhagic Fever

Germany
Probi AB

Completed

Probiotics in Prevention of Common Cold

Viral Infections of the Upper Respiratory Tract

Germany
Universität des Saarlandes
MeMed Diagnostics Ltd.

Completed

Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2 (DIRECTOR)

COVID-19 | SARS-CoV-2 | Viral Infection

Germany
University Hospital Tuebingen
Charite University, Berlin, Germany; Robert Bosch Gesellschaft für Medizinische...

Recruiting

Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome (YoFaPoCo)

Post-COVID-19 Syndrome | Fatigue Post Viral

Germany
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Germany

Viral Conjunctivitis

Germany
MediGene

Completed

Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers

Anogenital Warts

Germany
Adenovir Pharma AB
TFS Trial Form Support

Completed

Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)

Viral Conjunctivitis

Germany, Poland, Sweden
MediGene
Charité Research Organisation GmbH

Completed

Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

Genital Warts | Perianal Warts

Germany
Novartis
Novartis Vaccines

Completed

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Encephalitis, Tick-Borne

Germany
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
Hannover Medical School
Gilead Sciences; HepNet Study House, German Liverfoundation; German Center for...

Completed

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

Hepatitis E | Hepatitis Chronic Viral

Germany
Zydolab - Institute of Cytology and Immune Cytochemistry
Ruhr University of Bochum

Recruiting

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Condylomata Acuminata

Germany
Karoline Krause
Roche Pharma AG

Completed

Tocilizumab in Patients With Schnitzler's Syndrome (TOCISCH)

Schnitzler's Syndrome

Germany
Valneva Austria GmbH

Completed

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis

Austria, Germany
Ludwig-Maximilians - University of Munich
Freie Universität Berlin

Completed

Evaluation of a TDM Program for Intensive Care Patients in the Cerebrospinal Fluid (EMIL)

Ventriculitis, Infectious

Germany
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents

Hepatitis B

Germany
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Geneva; Wellcome Trust; KEMRI-Wellcome Trust Collaborative... and other collaborators

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Hemorrhagic Fever, Ebola

Germany
Valneva Austria GmbH

Completed

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Japanese Encephalitis

Germany, Austria
Innovative Molecules GmbH

Recruiting

Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers

Herpes Simplex Virus

Germany
University Hospital Muenster

Recruiting

Bronchoscopic Score for Prediction of Herpes Simplex-virus Type 1 (HSV-1) Reactivation

Tracheobronchitis | Herpes Simplex Infection

Germany
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and Raltegravir

Hepatitis C Virus

Germany
Enanta Pharmaceuticals, Inc

Completed

Two-way Interaction Between Alisporivir and EDP239

Hepatitis C Virus

Germany
University Hospital Tuebingen

Completed

NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression (COVID-19 NGS)

COVID-19

Germany
Merck Sharp & Dohme LLC

Completed

A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)

Papilloma Viral Infection

Belgium, Germany, Netherlands
Janssen R&D Ireland

Completed

A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382

Hepatitis C Virus Infection

Germany
Janssen R&D Ireland

Completed

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Hepatitis C

Germany
Valneva Austria GmbH

Completed

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis

Germany, Austria
Hannover Medical School
AbbVie

Terminated

MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV

Hepatitis C, Chronic

Germany
Valneva Austria GmbH

Completed

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Japanese Encephalitis

Germany, Austria
AstraZeneca

Terminated

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Germany
Bristol-Myers Squibb

Completed

Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)

Hepatitis

Germany
University of Regensburg

Unknown

Immune Monitoring of Hepatitis C Under DAA Therapy (IMHC)

Hepatitis C

Germany
Boehringer Ingelheim

Completed

Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis

Liver Cirrhosis | Hepatitis C

Germany
Boehringer Ingelheim

Completed

Drug-drug Interaction of BI 201335 and Microgynon

Hepatitis C, Chronic

Germany
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)

COVID-19

Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 (CYTOCOV-19)

COVID-19

Germany
University Hospital Tuebingen
Max-Planck-Institute Tuebingen

Unknown

Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning (COVID-19)

Covid19

Germany
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

Hepatitis C

Germany
University Hospital Tuebingen

Recruiting

Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach (COVID 19-VAC)

Genetic Predisposition

Germany
Corat Therapeutics Gmbh

Recruiting

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Covid19

Germany
Charite University, Berlin, Germany
Allergan

Terminated

Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients

Covid19

Germany
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

Covid19

Germany
Universität Duisburg-Essen

Recruiting

Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome (NASH-POCO)

Post-COVID-19 Syndrome

Germany
Charite University, Berlin, Germany

Completed

Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19 (AtemNHK)

Covid19 | Influenza A | Respiratory Disease

Germany
Universitätsklinikum Hamburg-Eppendorf
Federal Ministry of Health, Germany

Completed

Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients (HAM-SEX-C19)

Critical Illness | Covid19

Germany
Biogen
Elan Pharmaceuticals

Terminated

Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) (IRIS)

Leukoencephalopathy, Progressive Multifocal | Immune Reconstitution Inflammatory Syndrome

Germany, United States
Charite University, Berlin, Germany

Recruiting

Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients

Covid19

Germany
Drägerwerk AG & Co. KGaA

Terminated

Dräger COVID-19 Antigen Test Clinical Performance Study

Covid19

Germany
Charité Research Organisation GmbH
Bayer

Terminated

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat (NICCAM)

Covid19

Germany
Bitop AG

Completed

Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.

Acute Viral Pharyngitis

Germany

3

Subscribe